+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medical Polyglycolic Acid Market by Application (Drug Delivery, Surgical Sutures, Tissue Engineering), Product Type (Coated Filament, Filament Suture, Yarn), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6132367
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical polyglycolic acid is a biodegradable polymer renowned for its exceptional hydrolytic degradability, mechanical strength, and biocompatibility. Synthesized through ring-opening polymerization of glycolide monomers, this material has become foundational to a range of medical applications. Its predictable resorption profile and minimal inflammatory response position it as an optimal choice for temporary implantable devices where controlled degradation aligns with healing timelines.

Originally developed in the 1970s, this polymer has undergone successive refinements in molecular weight control and processing techniques. Consequently, it now underpins diverse therapeutic modalities, from implantable scaffolds that guide tissue regeneration to microsphere-based drug carriers designed for sustained release. As healthcare demands evolve, this polymer’s versatility continues to unlock novel treatment paradigms, reinforcing its status as a material of choice for innovators in medical devices and drug delivery systems.

Exploring Transformational Shifts That Are Redefining the Landscape of Medical Polyglycolic Acid Adoption and Innovation Across Key Sectors

Recent years have witnessed transformative shifts in polymer engineering that are reshaping the capabilities of medical polyglycolic acid. Advances in microfabrication have enabled the creation of sophisticated microspheres and polymer beads for targeted drug delivery, ensuring precise therapeutic dosing and enhanced bioavailability. Meanwhile, additive manufacturing techniques have accelerated the production of complex scaffold geometries, fostering breakthroughs in both hard and soft tissue engineering.

Moreover, regulatory frameworks are increasingly supportive of innovative biomaterial solutions. Expedited pathways for combination products have incentivized investment, while emerging guidelines on sustainability encourage manufacturers to optimize lifecycle impacts. These converging trends not only expand the material’s utility in implantable systems and surgical sutures but also catalyze cross-disciplinary collaborations that leverage polymer science to address unmet clinical needs.

Examining the Far-Reaching Consequences of United States Tariff Modifications on Medical Polyglycolic Acid Trade Logistics and Supply Chain Dynamics

The introduction of revised tariff policies in the United States as of 2025 has created significant ripples across the global supply chain for medical polyglycolic acid. By adjusting import duties on precursor glycolide and finished polymer forms, these measures have influenced cost structures for manufacturers and distributors alike. Consequently, sourcing strategies have been reevaluated to balance procurement costs against the imperative for uninterrupted production of critical medical devices.

In response, industry stakeholders have pursued diversified supply relationships and localized production partnerships. Collaborative agreements between polymer producers and device innovators have emerged to mitigate tariff impacts and stabilize raw material flows. At the same time, logistics networks have been reconfigured to leverage alternative routes, ensuring consistent delivery to manufacturing hubs. These adaptive strategies underscore the sector’s resilience amid shifting trade landscapes.

Unraveling Comprehensive Segmentation Insights to Illuminate Diverse Applications Product Types End Users and Distribution Channels in Medical Polyglycolic Acid

Insight into segmentation by application reveals that drug delivery continues to drive demand, encompassing both implantable systems and microspheres. Implantable systems momentum is propelled by advanced scaffolds designed to support cell proliferation and stents engineered to maintain vascular patency. Within microspheres, nanoparticles offer precision targeting at the cellular level, while polymer beads facilitate controlled release profiles. Surgical sutures also retain a pivotal role, extending across diverse procedures such as cardiovascular interventions, general surgical closures, gynecological repairs, ophthalmic reconstructions, and orthopedic fixations. Meanwhile, tissue engineering applications are bifurcated into hard tissue solutions for bone and cartilage regeneration and soft tissue constructs focused on cardiac and dermal repair.

Complementing these application dynamics are nuanced insights into product type preferences, with coated filaments enhancing handling characteristics and proprietary surface modifications, filament sutures available in monofilament formats for minimal tissue drag and multifilament variants for greater knot security, and engineered yarn constructs offering tailored tensile performance. End users span ambulatory surgical centers seeking minimally invasive procedural consumables, clinics emphasizing outpatient repair solutions, general hospitals with broad surgical portfolios, and specialized hospital units with niche requirements. Distribution channels have likewise diversified, ranging from dedicated hospital logistics networks to direct-to-provider online platforms and third-party distributors offering integrated supply management services.

Delving into Regional Dynamics That Shape Medical Polyglycolic Acid Demand Supply and Innovation Trends Across the Americas Europe Middle East Africa and Asia-Pacific

Regional demand in the Americas is characterized by robust clinical adoption driven by advanced healthcare infrastructure and a strong focus on minimally invasive procedures. Regulatory clarity combined with well-established reimbursement frameworks has facilitated rapid uptake of innovative polymer-based devices, particularly in both implantable drug delivery and tissue regeneration therapies.

In Europe, Middle East & Africa regions, adoption is influenced by heterogeneous regulatory environments and varying levels of healthcare investment. While Western European markets exhibit early adoption owing to established medical device approval pathways, emerging economies in the Middle East and Africa are progressively investing in surgical capacities and materials science research, creating new opportunities for collaborative ventures and technology transfer programs.

Across Asia-Pacific, the landscape is shaped by dynamic growth in manufacturing capabilities and increasing government support for biomedical research. Nations with robust industrial bases are leveraging low-cost production advantages to supply global markets, while expanding domestic healthcare infrastructure fuels local demand for advanced sutures, scaffold systems, and controlled-release formulations.

Highlighting Pioneering Organizations Advancing Medical Polyglycolic Acid Solutions Through Strategic Investments Partnerships and Technological Breakthroughs

A cohort of leading companies has emerged as catalysts in advancing medical polyglycolic acid innovations through dedicated research and strategic partnerships. Established device manufacturers have expanded their R&D capabilities by integrating polymer science specialists, enabling seamless development of next-generation implants and drug delivery platforms. Concurrently, specialty chemical producers are investing in scalable synthesis routes and quality management systems to meet the stringent purity requirements of medical applications.

Collaborative alliances between polymers developers and biotechnology firms have also become more prevalent, resulting in co-development agreements for scaffold materials optimized for specific tissue types. Strategic investments in pilot-scale manufacturing facilities further underscore the commitment to ensuring supply reliability and cost efficiencies. Through these concerted efforts, industry leaders are continuously refining product portfolios, enhancing performance parameters, and exploring new clinical indications for medical polyglycolic acid.

Formulating Actionable Recommendations to Empower Industry Leaders to Navigate Challenges and Capitalize on Opportunities in Medical Polyglycolic Acid

To navigate the evolving regulations and supply chain complexities, industry leaders should prioritize the establishment of diversified sourcing networks, incorporating both regional production sites and global raw material partnerships. This multifaceted approach can mitigate tariff impacts and reduce lead time uncertainties. In parallel, investing in process intensification techniques-such as continuous polymerization-can enhance manufacturing throughput while maintaining stringent quality controls.

Additionally, fostering cross-functional collaboration between polymer scientists, clinical researchers, and regulatory specialists will be instrumental in accelerating product pipelines. By integrating real-world clinical feedback into material design and validation workflows, organizations can ensure that emerging solutions address unmet therapeutic needs. Finally, stakeholders are encouraged to engage proactively with policymakers to shape supportive frameworks that balance innovation incentives with patient safety imperatives.

Detailing the Rigorous Research Methodology Employed to Ensure Reliability Validity and Depth in the Study of Medical Polyglycolic Acid Markets

The research methodology underpinning this analysis combined comprehensive secondary research with targeted primary interviews to ensure depth and accuracy. Secondary sources included peer-reviewed journals, patent filings, regulatory guidance documents, and technical white papers, which provided a foundational understanding of material properties, clinical applications, and manufacturing technologies.

Primary engagement constituted structured interviews with polymer chemists, regulatory advisors, device developers, and supply chain executives. This primary feedback was triangulated against secondary data to validate key trends and identify emerging challenges. Quality assurance protocols included cross-verification of expert insights and a multi-stage review process to ensure consistency, clarity, and adherence to rigorous analytical standards.

Summarizing Key Conclusions That Synthesize Critical Insights Trends and Strategic Imperatives for Stakeholders in Medical Polyglycolic Acid

In synthesizing insights across technological, regulatory, and supply chain dimensions, several critical imperatives have emerged. The continued evolution of manufacturing techniques will shape cost-competitiveness, while targeted applications in drug delivery and tissue engineering will drive material innovation. Moreover, adaptive supply strategies in response to tariff adjustments underscore the need for agile sourcing and partnership models.

As the landscape for medical polyglycolic acid advances, stakeholders must remain vigilant to shifts in regulatory frameworks and healthcare delivery paradigms. By aligning R&D investments with clinical priorities and fostering collaborative ecosystems, organizations can unlock the full potential of this polymer to enhance patient outcomes and sustain growth in an increasingly competitive environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Drug Delivery
      • Implantable Systems
        • Scaffolds
        • Stents
      • Microspheres
        • Nanoparticles
        • Polymer Beads
    • Surgical Sutures
      • Cardiovascular Surgery
      • General Surgery
      • Gynecological Surgery
      • Ophthalmic Surgery
      • Orthopedic Surgery
    • Tissue Engineering
      • Hard Tissue Engineering
        • Bone Tissue
        • Cartilage Tissue
      • Soft Tissue Engineering
        • Cardiac Tissue
        • Dermal Tissue
  • Product Type
    • Coated Filament
    • Filament Suture
      • Monofilament
      • Multifilament
    • Yarn
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Specialized Hospitals
  • Distribution Channel
    • Hospital Distribution
    • Online Sales
    • Third Party Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Ethicon, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • Poly-Med, Inc.
  • Evonik Industries AG
  • Gunze Limited
  • Advance Medical Polymer Co., Ltd.
  • Goodfellow Cambridge Ltd.
  • Synthetech Polymers, Inc.
  • Hunan Grand Poly Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of polyglycolic acid scaffolds in complex tissue regeneration procedures
5.2. Advancements in biodegradable PGA sutures for minimally invasive surgical techniques
5.3. Integration of polyglycolic acid microspheres in targeted drug delivery systems
5.4. Development of composite biomaterials combining PGA and collagen for wound healing
5.5. Regulatory approvals driving global expansion of medical PGA products in emerging markets
5.6. Innovations in 3D printed PGA-based implants for personalized orthopedic reconstruction
5.7. Cost reduction strategies in large scale production of high-purity medical polyglycolic acid
5.8. Partnerships between biotech startups and contract manufacturers to accelerate PGA development
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Polyglycolic Acid Market, by Application
8.1. Introduction
8.2. Drug Delivery
8.2.1. Implantable Systems
8.2.1.1. Scaffolds
8.2.1.2. Stents
8.2.2. Microspheres
8.2.2.1. Nanoparticles
8.2.2.2. Polymer Beads
8.3. Surgical Sutures
8.3.1. Cardiovascular Surgery
8.3.2. General Surgery
8.3.3. Gynecological Surgery
8.3.4. Ophthalmic Surgery
8.3.5. Orthopedic Surgery
8.4. Tissue Engineering
8.4.1. Hard Tissue Engineering
8.4.1.1. Bone Tissue
8.4.1.2. Cartilage Tissue
8.4.2. Soft Tissue Engineering
8.4.2.1. Cardiac Tissue
8.4.2.2. Dermal Tissue
9. Medical Polyglycolic Acid Market, by Product Type
9.1. Introduction
9.2. Coated Filament
9.3. Filament Suture
9.3.1. Monofilament
9.3.2. Multifilament
9.4. Yarn
10. Medical Polyglycolic Acid Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
10.5. Specialized Hospitals
11. Medical Polyglycolic Acid Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Distribution
11.3. Online Sales
11.4. Third Party Distributors
12. Americas Medical Polyglycolic Acid Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Medical Polyglycolic Acid Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Medical Polyglycolic Acid Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ethicon, Inc.
15.3.2. Medtronic plc
15.3.3. B. Braun Melsungen AG
15.3.4. Poly-Med, Inc.
15.3.5. Evonik Industries AG
15.3.6. Gunze Limited
15.3.7. Advance Medical Polymer Co., Ltd.
15.3.8. Goodfellow Cambridge Ltd.
15.3.9. Synthetech Polymers, Inc.
15.3.10. Hunan Grand Poly Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MEDICAL POLYGLYCOLIC ACID MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MEDICAL POLYGLYCOLIC ACID MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MEDICAL POLYGLYCOLIC ACID MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MEDICAL POLYGLYCOLIC ACID MARKET: RESEARCHAI
FIGURE 24. MEDICAL POLYGLYCOLIC ACID MARKET: RESEARCHSTATISTICS
FIGURE 25. MEDICAL POLYGLYCOLIC ACID MARKET: RESEARCHCONTACTS
FIGURE 26. MEDICAL POLYGLYCOLIC ACID MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MEDICAL POLYGLYCOLIC ACID MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY POLYMER BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY POLYMER BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY BONE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY BONE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARTILAGE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARTILAGE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIAC TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIAC TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DERMAL TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DERMAL TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COATED FILAMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COATED FILAMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY YARN, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY YARN, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HOSPITAL DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HOSPITAL DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 152. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 153. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 154. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 155. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 156. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 157. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 158. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 159. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 160. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 161. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 162. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 163. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 164. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 165. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 168. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 169. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. CANADA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SOFT TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY FILAMENT SUTURE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 298. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 299. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 300. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY IMPLANTABLE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 306. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 307. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 308. GERMANY MEDICAL POLYGLYCOLIC ACID MARKET SIZE, BY HARD TISS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medical Polyglycolic Acid market report include:
  • Ethicon, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • Poly-Med, Inc.
  • Evonik Industries AG
  • Gunze Limited
  • Advance Medical Polymer Co., Ltd.
  • Goodfellow Cambridge Ltd.
  • Synthetech Polymers, Inc.
  • Hunan Grand Poly Co., Ltd.